Long non coding RNAs in Breast Cancer Prevention and Treatment, 1st ed. 2019
Auteurs : Russo Jose, Barton Maria, Santucci-Pereira Julia
There is no single preventive agent that can stop the incidence of breast cancer?the malignant disease most frequently diagnosed in women of all races and nationalities. Furthermore, its incidence around the globe is increasing in industrialized countries. The worldwide incidence of breast cancer has increased 30-40% since the 1970s, reaching an excess of 1,390,000 new cases and a mortality of more than 460,000 cases in 2015. Therefore, what is needed is the development of rational strategies for the prevention of this fatal disease.
1 The paradigms in breast cancer prevention.- 2 The role genistein in breast cancer prevention.- 3 The role of Omega 3 in breast cancer prevention.- 4 Is there a role for Raloxifene and Tamoxifene for the prevention of breast cancer?.- 5 Aromatase inhibitors for breast cancer prevention.- 6 Inhibition of the estrogen metabolism pathways as a preventive strategy in hormone dependent cancer.- 7 The molecular mechanisms of the dual effect of pregnancy in risk and prevention of breast cancer.- 8 Beyond aspirin in breast cancer prevention.- 9 Role of diet in the prevention of breast cancer.- 10 Vaccination against breast cancer and its role in prevention.
Jose Russo, MD, FACP, is Professor and Senior Member, Fox Chase Center Center-Temple Health, Director of the Breast Cancer and the Environment Research Center, Fox Chase Cancer Center, Director, Irma H. Russo, MD-Breast Cancer Research Laboratories, Fox Chase Cancer Center, Adjunct Professor of Pathology and Cell Biology, Jefferson Medical College, and Professor of Biochemistry, Temple Medical School.
Maria Barton, MS, is a PhD Candidate in Biochemistry, Temple University/Fox Chase Center, The Irma H. Russo, MD-Breast Cancer Research Laboratories.
Julia Santucci-Pereira, PhD, is Researcher, Fox Chase Cancer Center, The Irma H. Russo, MD-Breast Cancer Research Laboratories.
Explores both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer
Skillfully reviews the pathophysiological aspects of the mucin glycoproteins in malignancies
Provides an updated account of the status of bromelain and N-acetylcysteine in cancer therapy
Develop the idea of using these two drugs as a combination formulation for mucin-depleting effects
Date de parution : 12-2019
Ouvrage de 302 p.
15.5x23.5 cm
Publication abandonnée
Thème de Long non coding RNAs in Breast Cancer Prevention and... :
Mots-clés :
Long non codiing; Long non coding RNAs; RNAs; nucleotides; pluripotency